Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, April 26, 2023
[ Wed, Apr 26th 2023
] - WOPRAI
[ Wed, Apr 26th 2023
] - WOPRAI
[ Wed, Apr 26th 2023
] - WOPRAI
[ Wed, Apr 26th 2023
] - WOPRAI
[ Wed, Apr 26th 2023
] - WOPRAI
[ Wed, Apr 26th 2023
] - WOPRAI
[ Wed, Apr 26th 2023
] - WOPRAI
[ Wed, Apr 26th 2023
] - WOPRAI
[ Wed, Apr 26th 2023
] - WOPRAI
[ Wed, Apr 26th 2023
] - WOPRAI
[ Wed, Apr 26th 2023
] - WOPRAI
[ Wed, Apr 26th 2023
] - WOPRAI
[ Wed, Apr 26th 2023
] - WOPRAI
[ Wed, Apr 26th 2023
] - WOPRAI
[ Wed, Apr 26th 2023
] - WOPRAI
[ Wed, Apr 26th 2023
] - WOPRAI
[ Wed, Apr 26th 2023
] - WOPRAI
[ Wed, Apr 26th 2023
] - WOPRAI
Tue, April 25, 2023
[ Tue, Apr 25th 2023
] - WOPRAI
[ Tue, Apr 25th 2023
] - WOPRAI
[ Tue, Apr 25th 2023
] - WOPRAI
[ Tue, Apr 25th 2023
] - WOPRAI
[ Tue, Apr 25th 2023
] - WOPRAI
[ Tue, Apr 25th 2023
] - WOPRAI
[ Tue, Apr 25th 2023
] - WOPRAI
[ Tue, Apr 25th 2023
] - WOPRAI
[ Tue, Apr 25th 2023
] - WOPRAI
[ Tue, Apr 25th 2023
] - WOPRAI
[ Tue, Apr 25th 2023
] - WOPRAI
[ Tue, Apr 25th 2023
] - WOPRAI
Charles Duncan Initiated (XENE) at Buy and Held Target at $58 on, Apr 25th, 2023
Charles Duncan of Cantor Fitzgerald, Initiated "Xenon Pharmaceuticals Inc." (XENE) at Buy and Held Target at $58 on, Apr 25th, 2023.
Charles has made no other calls on XENE in the last 4 months.
There are 2 other peers that have a rating on XENE. Out of the 2 peers that are also analyzing XENE, 0 agree with Charles's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Charles
- Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $50 on, Friday, April 21st, 2023
- Brian Abrahams of "RBC Capital" Reiterated at Buy and Held Target at $51 on, Wednesday, March 22nd, 2023
